Search Results 121-130 of 16747 for CLL

  1. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  2. Clinical trials - Oncology (Medical)

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  3. Obinutuzumab (intravenous route) - Mayo Clinic

    Description. Obinutuzumab injection is used together with other medicines (eg, chlorambucil) to treat chronic lymphocytic leukemia (CLL).

  4. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  5. Oncology (Medical) - Clinical trials - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  6. Asher A. Chanan-Khan, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Asher A. Chanan-Khan, M.D., investigates treatments for chronic lymphocytic leukemia (CLL), Waldenstrom macroglobulinemia and ...

  7. Shanafelt Archives - Mayo Clinic News Network

    ... CLL Patients. ASCO Abstract Number: 6522 An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) ...

  8. Mazie Tsang, M.D. - Mayo Clinic Faculty Profiles

    Focus areas · Decision-making for older adults with advanced cancers. Dr. · Managing older adults with chronic lymphocytic leukemia (CLL). CLL mainly affects ...

  9. Study to Assess the Safety and Effectiveness of Shingrix Vaccine in Patients with Hematologic Malignancies - Mayo Clinic

    ... CLL to patients with untreated intermediate and high-risk CLL. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  10. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Diagnosis of chronic lymphocytic leukemia (CLL) according to the National Cancer Institute (NCI) criteria or small lymphocytic lymphoma (SLL) according to ...